List of Excipients in API GEMIFLOXACIN MESYLATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing GEMIFLOXACIN MESYLATE
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Merus Labs International Inc | FACTIVE | gemifloxacin mesylate | 44001-321 | CELLULOSE, MICROCRYSTALLINE | |
Merus Labs International Inc | FACTIVE | gemifloxacin mesylate | 44001-321 | CROSPOVIDONE | |
Merus Labs International Inc | FACTIVE | gemifloxacin mesylate | 44001-321 | HYPROMELLOSE 2910 | |
Merus Labs International Inc | FACTIVE | gemifloxacin mesylate | 44001-321 | MAGNESIUM STEARATE | |
Merus Labs International Inc | FACTIVE | gemifloxacin mesylate | 44001-321 | POLYETHYLENE GLYCOL 4000 | |
Merus Labs International Inc | FACTIVE | gemifloxacin mesylate | 44001-321 | POLYETHYLENE GLYCOL 6000 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for GEMIFLOXACIN MESYLATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
GEMIFLOXACIN MESYLATE drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Merus Labs International Inc | gemifloxacin mesylate | 44001-321 |
Vansen Pharma Inc | gemifloxacin mesylate | 44004-321 |
>Company | >Ingredient | >NDC |
GEMIFLOXACIN MESYLATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
GEMIFLOXACIN MESYLATE drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Merus Labs International Inc | gemifloxacin mesylate | 44001-321 |
Vansen Pharma Inc | gemifloxacin mesylate | 44004-321 |
>Company | >Ingredient | >NDC |
GEMIFLOXACIN MESYLATE drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
GEMIFLOXACIN MESYLATE drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Merus Labs International Inc | gemifloxacin mesylate | 44001-321 |
Vansen Pharma Inc | gemifloxacin mesylate | 44004-321 |
>Company | >Ingredient | >NDC |
GEMIFLOXACIN MESYLATE drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
GEMIFLOXACIN MESYLATE drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Merus Labs International Inc | gemifloxacin mesylate | 44001-321 |
Vansen Pharma Inc | gemifloxacin mesylate | 44004-321 |
>Company | >Ingredient | >NDC |
GEMIFLOXACIN MESYLATE drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
GEMIFLOXACIN MESYLATE drug variants containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Merus Labs International Inc | gemifloxacin mesylate | 44001-321 |
Vansen Pharma Inc | gemifloxacin mesylate | 44004-321 |
>Company | >Ingredient | >NDC |
GEMIFLOXACIN MESYLATE drug variants not containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
GEMIFLOXACIN MESYLATE drug variants containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Merus Labs International Inc | gemifloxacin mesylate | 44001-321 |
Vansen Pharma Inc | gemifloxacin mesylate | 44004-321 |
>Company | >Ingredient | >NDC |
GEMIFLOXACIN MESYLATE drug variants not containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
GEMIFLOXACIN MESYLATE drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Merus Labs International Inc | gemifloxacin mesylate | 44001-321 |
Vansen Pharma Inc | gemifloxacin mesylate | 44004-321 |
>Company | >Ingredient | >NDC |
GEMIFLOXACIN MESYLATE drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
GEMIFLOXACIN MESYLATE drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Merus Labs International Inc | gemifloxacin mesylate | 44001-321 |
Vansen Pharma Inc | gemifloxacin mesylate | 44004-321 |
>Company | >Ingredient | >NDC |
GEMIFLOXACIN MESYLATE drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.